Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.IMI Intelligent Medical Implants has appointed Stephen McCormack as its new CEO. Dr McCormack was previously chairman of the board and will remain as a board member.
Subscribe to our email newsletter
Dr McCormack has more than 20 years experience in medical technologies, from fundamental research to product development. He was previously a partner of Global Life Science Ventures (GLSV) and led their investment in IMI.
Prior to GLSV, he co-founded NeuroSystec for the development of therapeutics to treat neurological diseases and AlleCure which was merged with two other biotechnology companies and taken public as MannKind.
Vin Bucci, chairman of IMI, said: “We are very pleased to have Stephen leading IMI. His experience and familiarity with the field will be crucial to the success of the company.”